Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
126970121	12697012	1	I	20160223	20160822	20160830	20160830	EXP		CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-070749	BRISTOL MYERS SQUIBB		78.00	YR		F	Y	0.00000		20160830		CN	CN	CN

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	DECHAL	RECHAL	LOT NUM	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
126970121	12697012	1	PS	EFAVIRENZ	EFAVIRENZ	1	Oral	600 MG, QD	U	Y	825A15120	21360	600	MG	TABLET	QD
126970121	12697012	2	SS	LAMIVUDINE.	LAMIVUDINE	1	Unknown	300 MG, UNK	U	N		0	300	MG
126970121	12697012	3	SS	TENOFOVIR DISOPROXIL FUMARATE.	TENOFOVIR DISOPROXIL FUMARATE	1	Unknown	300 MG, UNK	U	N		0	300	MG

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
126970121	12697012	1	HIV infection
126970121	12697012	2	HIV infection
126970121	12697012	3	HIV infection

Outcome of event

Event ID	CASEID	OUTC COD
126970121	12697012	HO

Reactions reported

Event ID	CASEID	PT
126970121	12697012	Abdominal discomfort
126970121	12697012	Diarrhoea
126970121	12697012	Nausea

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT
126970121	12697012	1	20160203
126970121	12697012	2	20160203
126970121	12697012	3	20160203